cbdMD
YCBD
43 hedge funds and large institutions have $1.63M invested in cbdMD in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
367% more call options, than puts
Call options by funds: $14K | Put options by funds: $3K
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
0% less ownership
Funds ownership: 0.04% → 0.03% (-0%)
7% less funds holding
Funds holding: 46 → 43 (-3)
8% less capital invested
Capital invested by funds: $1.77M → $1.63M (-$140K)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Merlin Capital
Newport,
Rhode Island
|
+$84.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$25K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$17.4K |
| 4 |
CL
Choreo LLC
Rockford,
Illinois
|
+$14K |
| 5 |
VF
Virtu Financial
New York
|
+$4.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$125K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$61K |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$32K |
| 4 |
Jane Street
New York
|
-$19K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$4K |
YCBD Hedge Fund Activity: Q4 2022 in Review
43 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q4 2022, worth a combined $1.63M — down 7.9% from $1.77M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of YCBD and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was Merlin Capital, adding an estimated $84.4K. The largest seller was Ameriprise, exiting entirely with an estimated $125K sold.
- 43 institutional investors held cbdMD (YCBD) as of Q4 2022, down from 46 in Q3 2022.
- Funds reported $1.63M of cbdMD stock for Q4 2022, down 7.9% quarter-over-quarter.
- 5 funds opened new cbdMD positions in Q4 2022 and 7 closed out, a net change of -2 holders.
- The largest cbdMD buyer in Q4 2022 was Merlin Capital, an estimated $84.4K added.
- The largest cbdMD seller in Q4 2022 was Ameriprise, an estimated $125K sold.
Based on aggregated 13F filings for Q4 2022.